| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/06/1998 | WO1998033904A2 An antisense oligonucleotide preparation method |
| 08/06/1998 | WO1998033791A1 Dihydropyrimidone derivatives as npy antagonists |
| 08/06/1998 | WO1998033508A1 Calcareous material |
| 08/06/1998 | WO1998033492A1 Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 08/06/1998 | WO1998033480A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 08/06/1998 | WO1998023959A3 Diagnosis and treatment of insulin-dependent diabetes mellitus |
| 08/06/1998 | WO1998018440A3 Use of inhibitors of the activity of retinoic acid for treating sensitive skin |
| 08/06/1998 | DE19704244A1 5-Hydroxy-alkyl substituierte Phenyle 5-hydroxy-alkyl-substituted phenyls |
| 08/06/1998 | DE19704243A1 Neue 2-Amino-substituierte Pyridine New 2-amino-substituted pyridines |
| 08/06/1998 | CA2622476A1 System, method and composition for dialysis and shock treatment |
| 08/06/1998 | CA2279594A1 Calcareous material |
| 08/06/1998 | CA2278595A1 Secreted proteins and polynucleotides encoding them |
| 08/06/1998 | CA2277965A1 Dihydropyrimidone derivatives as npy antagonists |
| 08/05/1998 | EP0856579A1 An antisense oligonucleotide preparation method |
| 08/05/1998 | EP0856514A1 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives |
| 08/05/1998 | EP0855914A1 Stable formulations of mhc-peptide complexes |
| 08/05/1998 | EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/05/1998 | EP0642518B1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism |
| 08/05/1998 | EP0553263B1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
| 08/05/1998 | CN1189834A Condesned thiazole derivatives, having 5-HT receptor affinity |
| 08/04/1998 | US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 08/04/1998 | US5789406 Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them |
| 08/04/1998 | US5789401 Synergistic effect |
| 08/04/1998 | US5789400 Cardiovascular disorders |
| 08/04/1998 | US5789380 Agents for inhibiting accumulation of visceral fat |
| 08/04/1998 | US5789197 Microsomal triglyceride transfer protein |
| 08/04/1998 | US5788984 Gestodene-containing agent for transdermal administration |
| 08/04/1998 | CA2161533C Indole derivatives |
| 08/04/1998 | CA2132706C Acylaminoindole derivatives as 5-ht1 agonists |
| 08/04/1998 | CA2101275C Methods for the treatment of osteoporosis |
| 08/04/1998 | CA2071093C Ethanolamine benzoate derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/30/1998 | WO1998032753A1 THIAZOLE BENZENESULFONAMIDES AS β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 07/30/1998 | WO1998032751A1 Process for the production of semi synthetic statins via novel intermediates |
| 07/30/1998 | WO1998032742A1 Novel amide derivatives and medicinal compositions thereof |
| 07/30/1998 | WO1998032740A1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 07/30/1998 | WO1998032460A1 Methods for diagnosing and treating body weight related disorders in animals |
| 07/30/1998 | WO1998032455A1 The extract of pine needle and the use thereof |
| 07/30/1998 | WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | WO1998032441A1 Use of central cannabinoid receptor antagonists for regulating appetence |
| 07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
| 07/30/1998 | WO1998024780A3 Substituted pyrimidinone and pyridinone compounds and their use |
| 07/30/1998 | WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity |
| 07/30/1998 | DE19718245C1 Synthetic tri:glyceride(s) useful as food additives |
| 07/30/1998 | CA2279261A1 The extract of pine needle and the use thereof |
| 07/30/1998 | CA2278739A1 Thiazole benzenesulfonamides as .beta.3 agonists for the treatment of diabetes and obesity |
| 07/30/1998 | CA2278661A1 Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour reguler l'appetance |
| 07/30/1998 | CA2278603A1 Process for the production of semi synthetic statins via novel intermediates |
| 07/30/1998 | CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | CA2276691A1 Methods for diagnosing and treating body weight related disorders in animals |
| 07/29/1998 | EP0855396A1 Thioctic acid metabolites and methods of use thereof |
| 07/29/1998 | EP0855182A1 3-Deoxyglucosone production inhibitor |
| 07/29/1998 | EP0854884A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor |
| 07/29/1998 | EP0854712A1 Use of creatine analogues for the treatment of disorders of glucose metabolism |
| 07/29/1998 | EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 07/29/1998 | EP0854710A2 USE OF A $g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 07/29/1998 | EP0854681A1 Therapeutic diet for dogs with lymphoma |
| 07/29/1998 | EP0749428B1 Isoxazoline compounds as inhibitors of tnf release |
| 07/29/1998 | CN1189166A Somatostatin peptides |
| 07/29/1998 | CN1189151A 维生素d类似物 Vitamin d analogues |
| 07/29/1998 | CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis |
| 07/29/1998 | CN1189098A Pharmaceutical composition stablilized with basic agent |
| 07/29/1998 | CN1188651A High-efficient pure natural hypoglycemic agent |
| 07/29/1998 | CN1188642A High-polymer encapsulated insulin microsome and its preparation method and use |
| 07/29/1998 | CN1039327C Novel thio-substituted nitrogen-containing heterocyclic phosphonate compounds, pharmaceutical compositions and pharmacy application |
| 07/29/1998 | CN1039326C Phosphinyloxy propanaminium inner salt derivatives |
| 07/29/1998 | CN1039322C Preparation method of indole derivatives |
| 07/28/1998 | US5786465 Secreted proteins and polynucleotides encoding them |
| 07/28/1998 | US5786368 Inhibitors of glycolipids |
| 07/28/1998 | US5786356 Selective β3 adrenergic agonists |
| 07/28/1998 | US5786347 Vitamin D amine and amide derivatives |
| 07/28/1998 | US5786329 Muscular disorders |
| 07/28/1998 | US5785967 Antibodies immunoreactive with leukemia inhibitory factor receptors |
| 07/28/1998 | CA2105791C Nutrition for persons undergoing radiation therapy and/or chemotherapy |
| 07/28/1998 | CA2105790C Nutrition for persons infected with human immunodeficiency virus |
| 07/23/1998 | WO1998032017A2 Modulators of insulin receptor activity |
| 07/23/1998 | WO1998031819A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase |
| 07/23/1998 | WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | WO1998031707A2 Transgenic animals with disrupted npy y1 receptor genes |
| 07/23/1998 | WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | WO1998031390A1 Obesity protein formulations |
| 07/23/1998 | WO1998031366A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 07/23/1998 | WO1998031361A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same |
| 07/23/1998 | WO1998031346A1 Preparation of particles for inhalation |
| 07/23/1998 | WO1998020906A3 Treatment of diabetes with transcription factor gene |
| 07/23/1998 | DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use |
| 07/23/1998 | CA2278787A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase |
| 07/23/1998 | CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | CA2278023A1 Modulators of insulin receptor activity |
| 07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | CA2277282A1 Obesity protein formulations |
| 07/23/1998 | CA2276467A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 07/23/1998 | CA2271237A1 Transgenic animals with disrupted npy y1 receptor genes |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853615A1 Piperidine compounds as calcium channel blockers |
| 07/22/1998 | EP0667914B1 Fo-1289 substance and its production |
| 07/22/1998 | EP0655070B1 Triantennary cluster glycosides, their preparation and use |
| 07/22/1998 | CN1188485A Glucagon-like peptide-2 and its therapeutic use |
| 07/22/1998 | CN1187991A Calcium tablet |
| 07/21/1998 | US5783600 Carboxyalkylethers, formulations, and treatment of vascular diseases |
| 07/21/1998 | US5783561 Anti-gram-positive bacterial methods and materials |